Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB

Hui-Kuan Lin1, Guocan Wang, Zhenbang Chen

  • 1Department of Pathology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. hklin@mdanderson.org

Nature Cell Biology
|March 10, 2009
PubMed

Insights

Akt (also known as protein kinase B or PKB) directly phosphorylates Skp2, activating its E3 ligase activity. This Akt-dependent pathway promotes cell proliferation, migration, and tumorigenesis, offering a novel target for cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Skp2, an F-box protein, forms the SCF E3 ligase complex essential for ubiquitylation.
  • Skp2-mediated p27 degradation regulates cell cycle entry.
  • Skp2 overexpression and cytosolic accumulation are linked to tumorigenesis, but the latter's role is unclear.

Purpose of the Study:

  • To investigate the interaction between Akt/PKB and Skp2.
  • To elucidate the functional significance of Skp2 phosphorylation by Akt.
  • To determine the role of cytosolic Skp2 in cancer progression.

Main Methods:

  • Protein interaction studies
  • In vitro kinase assays
  • Site-directed mutagenesis
  • Cell proliferation and migration assays
  • Analysis of human cancer specimens

Main Results:

  • Akt/PKB directly phosphorylates Skp2.
  • Phosphorylation by Akt enhances SCF complex formation and E3 ligase activity.
  • A phosphorylation-defective Skp2 mutant shows impaired tumorigenesis and proliferation.
  • Akt-mediated phosphorylation induces 14-3-3beta-dependent Skp2 cytosolic relocalization.
  • Cytosolic Skp2 promotes cell migration.
  • Activated Akt correlates with cytosolic Skp2 accumulation in human cancers.

Conclusions:

  • Akt/PKB directly phosphorylates and activates Skp2's E3 ligase activity.
  • This novel Akt/PKB-Skp2 signaling pathway is proto-oncogenic, driving cell proliferation, migration, and tumorigenesis.
  • Cytosolic Skp2 plays a key role in regulating cell migration, and its accumulation is linked to cancer progression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...